Suraj Kapa is a cardiac electrophysiologist at Mayo Clinic. He started on faculty at Mayo in 2013 after completing his internal medicine training at Mayo Clinic in Rochester, MN and cardiology and electrophysiology fellowships at the University of Pennsylvania. Over the course of his career he has published over 200 peer-reviewed articles and book chapters and given over 100 invited lectures nationally and internationally. He has been highly sought after for his views on the future of digital health, having spoken at CES, Webit, Exponential Medicine and for venture groups on behalf of Frost & Sullivan, at the Harvard Club, and in other venues. Over the course of his tenure at Mayo he has filed over 30 patents resulting in start-up companies related to non-invasive carbon beam ablation and artificial intelligence algorithms for early ECG diagnosis. In addition, he has been invited to serve as a strategic advisor both for his clinical expertise with companies such as Boston Scientific and Abbott, a business/managerial advisor for start-ups such as Nanowear, Inc, and as a digital advisor focused on AI integration into their data architectures for Myant (a wearable sensor company), BioSig (a signal processing company for whom he helped develop the data science infrastructure), and others. He is a well-recognized expert in digital health, healthcare delivery, and AI integration into healthcare, serving on journal editorial boards and also as a vice-chair, author, or reviewer on several scientific consensus statements. In addition, his work on digital tools to address the COVID-19 pandemic in 2020 has been featured in the Wall Street Journal, Stat, and on CNBC. Currently, he also serves as the lead for innovation related to virtual (VR) and augmented (AR) reality at Mayo as well as for AI integration into knowledge management and delivery for the Mayo enterprise. Prior to this, Dr. Kapa led global marketing for the cardiovascular department across all sites in the Mayo enterprise, expanding digital and international demand and demonstrating significant year over year growth in both net revenue and patient demand over his tenure. In that capacity, he led several initiatives to evaluate market trends regionally, domestically, and globally related to patient referral patterns and disease incidence to strategize digital marketing efforts. In 2020, the digital demand revenue directly attributed to his team’s efforts was more than $80 million with a >2:1 net return on investment and consistent year over year growth during his 4 year tenure.
Connect On: LinkedIn